FDA clears smart inhaler cap from Cognita Labs
Known as CapMedic, the device signals patients to help them use inhalers correctly. Developers hope the feedback mechanism distinguishes the device from other smart inhalers.
Known as CapMedic, the device signals patients to help them use inhalers correctly. Developers hope the feedback mechanism distinguishes the device from other smart inhalers.
The company's lead product candidate, CG0070, has completed a Phase II study and will be tested in another trial, combined with Merck's Keytruda.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Irvine-based Agendia complains that while it spent huge amounts of time, energy and resources to gain formal approval from U.S. Food and Drug Administration for its breast-cancer test, its chief rival, Genomic Health Inc., has chosen to bypass federal ...